Michael J. Bickerdike

Author

University of Auckland

Also Known As

Michael Bickerdike, Michael J. Bickerdike

Publications

308

Citations

H-Index

Concepts

All Affiliations

University of Auckland

About

Michael J. Bickerdike is an author at University of Auckland specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	201
2	Social Sciences	3	3	101
3	Behavioral Sciences	2	2	58
4	Anesthesia	1	1	12
5	Biochemistry	1	1	26

Michael J. Bickerdike

Publications

215

Citations

H-Index

Page 1

	Year	Citations
NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke Michael J. Bickerdike, Gregory B. Thomas, D. C. Batchelor, Journal of the Neurological Sciences Rat ModelCerebral Vascular RegulationNeuroinflammationMolecular PharmacologyStroke	2009	62
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze Michael J. Bickerdike, C.A. Marsden, Colin T. Dourish, European Journal of Pharmacology NeurophysiologyMedicinePhysiologyNeurotransmitterNeuropharmacology	1994	43
Striatal Acetylcholine Release Correlates with Behavioral Sensitization in Rats Withdrawn from Chronic Amphetamine Michael J. Bickerdike, Elizabeth D. Abercrombie Journal of Pharmacology and Experimental Therapeutics NeuropsychologyBehavioral SciencesStriatal Acetylcholine ReleasePsychoactive DrugBehavioral Neuroscience	1997	42
Pyrrolo(iso)quinoline derivatives as 5-HT2C receptor agonists David R. Adams, Jonathan Bentley, Karen Benwell, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineReceptor (Biochemistry)	2005	26
Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine Elizabeth D. Abercrombie, Michael J. Bickerdike Schizophrenia Research NeuropsychologyBehavioral SciencesStriatal Acetylcholine ReleasePsychoactive DrugBehavioral Neuroscience	1997	16
AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma Michael J. Bickerdike, Imane Nafia, Alban Bessede, BMC Cancer	2024	14
Ketamine esters and amides as short-acting anaesthetics: Structure-activity relationships for the side-chain Ivaylo Dimitrov, Martyn Harvey, Logan J. Voss, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryMedicineShort-acting AnaestheticsAnesthetic Mechanism	2019	12

Page 1